A. Loebel

458 total citations
11 papers, 359 citations indexed

About

A. Loebel is a scholar working on Psychiatry and Mental health, Philosophy and Experimental and Cognitive Psychology. According to data from OpenAlex, A. Loebel has authored 11 papers receiving a total of 359 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Psychiatry and Mental health, 6 papers in Philosophy and 2 papers in Experimental and Cognitive Psychology. Recurrent topics in A. Loebel's work include Schizophrenia research and treatment (8 papers), Mental Health and Psychiatry (6 papers) and Health Systems, Economic Evaluations, Quality of Life (2 papers). A. Loebel is often cited by papers focused on Schizophrenia research and treatment (8 papers), Mental Health and Psychiatry (6 papers) and Health Systems, Economic Evaluations, Quality of Life (2 papers). A. Loebel collaborates with scholars based in United States. A. Loebel's co-authors include David Mayerhoff, Jeffrey A. Lieberman, José Alvir, John M. Kane, S. Szymanski, Miranda Chakos, S. Geisler, A. Koreen, D. Jody and Krithika Rajagopalan and has published in prestigious journals such as American Journal of Psychiatry, Biological Psychiatry and Schizophrenia Research.

In The Last Decade

A. Loebel

11 papers receiving 344 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A. Loebel United States	7	270	99	89	55	43	11	359
Jozef Peuskens Belgium	11	187 0.7×	152 1.5×	58 0.7×	34 0.6×	41 1.0×	28	423
T. Rolfe Australia	8	271 1.0×	95 1.0×	64 0.7×	81 1.5×	36 0.8×	12	474
M. Lang Canada	5	210 0.8×	88 0.9×	52 0.6×	77 1.4×	50 1.2×	7	410
Christian Scharfetter Switzerland	8	126 0.5×	96 1.0×	75 0.8×	39 0.7×	27 0.6×	32	306
Dan Prelipceanu Romania	7	305 1.1×	64 0.6×	57 0.6×	49 0.9×	46 1.1×	15	403
R. Conley United States	7	353 1.3×	128 1.3×	60 0.7×	63 1.1×	29 0.7×	11	443
Boris Rauchverger Israel	4	232 0.9×	192 1.9×	33 0.4×	34 0.6×	80 1.9×	5	378
B. Lomas Australia	6	262 1.0×	82 0.8×	89 1.0×	34 0.6×	26 0.6×	6	330
Seth Apter United States	11	407 1.5×	220 2.2×	142 1.6×	33 0.6×	92 2.1×	17	573
Alfredo Martínez‐Larrea Spain	7	225 0.8×	52 0.5×	42 0.5×	19 0.3×	39 0.9×	7	373

Countries citing papers authored by A. Loebel

Since Specialization

Citations

This map shows the geographic impact of A. Loebel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Loebel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Loebel more than expected).

Fields of papers citing papers by A. Loebel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Loebel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Loebel. The network helps show where A. Loebel may publish in the future.

Co-authorship network of co-authors of A. Loebel

This figure shows the co-authorship network connecting the top 25 collaborators of A. Loebel. A scholar is included among the top collaborators of A. Loebel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Loebel. A. Loebel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

O’Day, Ken, et al.. (2013). Long-term cost-effectiveness of atypical antipsychotics in the treatment of adults with schizophrenia in the US. ClinicoEconomics and Outcomes Research. 5. 459–459. 18 indexed citations

Szymanski, S., Jeffrey A. Lieberman, José Alvir, et al.. (1995). Gender differences in onset of illness, treatment response, course, and biologic indexes in first-episode schizophrenic patients. American Journal of Psychiatry. 152(5). 698–703. 255 indexed citations

Loebel, A., J.A. Lieberman, José Alvir, et al.. (1995). Time to treatment response in successive episodes of early onset schizophrenia. Schizophrenia Research. 15(1-2). 158–158. 11 indexed citations

Szymanski, S., David Mayerhoff, A. Loebel, et al.. (1994). Clozapine response in treatment-refractory first-episode schizophrenia. Biological Psychiatry. 35(4). 278–280. 29 indexed citations

Koreen, A., J.A. Lieberman, José Alvir, et al.. (1994). Relation of plasma fluphenazine levels to treatment response and extrapyramidal side effects in first-episode schizophrenic patients. American Journal of Psychiatry. 151(1). 35–39. 12 indexed citations

Bilder, Robert M., H. Wu, Gustav Degreef, et al.. (1993). Yakovlevian torque is absent in first episode schizophrenia. Schizophrenia Research. 9(2-3). 193–193. 7 indexed citations

Loebel, A., et al.. (1993). Consistency of treatment response across successive psychotic episodes in recent-onset schizophrenia. Schizophrenia Research. 9(2-3). 243–243. 5 indexed citations

Koreen, A., Jeffrey A. Lieberman, José Alvir, et al.. (1993). Plasma homovanillic acid in first-episode schizophrenia: Psychopathology and treatment response. Schizophrenia Research. 9(2-3). 240–240. 1 indexed citations

Loebel, A., J.A. Lieberman, David Mayerhoff, et al.. (1991). Correlates of course and outcome in first-episode schizophrenia. Schizophrenia Research. 4(3). 290–290. 3 indexed citations

10.

Lieberman, Jeffrey A., David Mayerhoff, A. Loebel, et al.. (1991). Biologic indices of heterogeneity in schizophrenia: Relationship to psychopathology and treatment outcome. Schizophrenia Research. 4(3). 289–290. 3 indexed citations

11.

Bilder, Robert M., G. Reiter, David Mayerhoff, et al.. (1991). Neuropsychological studies of first episode schizophrenia. Schizophrenia Research. 4(3). 381–382. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact